ISPOR Real-World Evidence Summit 28-30 September 2025 | Tokyo, Japan

Published Sep 9, 2025

Lawrenceville, NJ, USA— September 9,  2025—ISPORThe Professional Society for Health Economics and Outcomes Research (HEOR) announced details for its ISPOR Real-World Evidence Summit 2025: Through The Lens of Asia Pacific. The Summit brings together top experts, decision makers, and industry leaders to explore the latest breakthroughs, share cutting-edge research, and discuss innovative solutions to the region’s most pressing healthcare challenges.

The Summit features plenary sessions, workshops, and breakout discussions on today’s most pressing topics, each tied to the bigger picture of real-world evidence (RWE) including health equity, HTA, value-based healthcare, generative AI, health policy, drug price negotiations, and beyond.

Sessions include:

Plenary 1: Realizing RWE Potential in Asia Pacific: Opportunities, Challenges, and Progress
Monday 29, September 2025  
This plenary session examines the evolving landscape of real-world evidence across the Asia Pacific region, where adoption varies significantly between countries despite growing interest. 

Speakers Include:

  • Moderator: Fei-Yuan Sharon Hsiao, PhD, College of Medicine, National Taiwan University, Taipei, Taiwan
  • Mahendra Kumar Rai, PhD, EVERSANA, Singapore, Singapore
  • Sallie Pearson, PhD, The University of New South Wales, Sydney, Australia
  • Bor-Sheng Ko, PhD, MD, National Taiwan University Hospital, New Taipei City, Taiwan
  • Boxiong Tang, PhD, MD, TZ Health, Collegeville, PA, United States
  • Yoshiaki Uyama, PhD, Pharmaceuticals & Medical Devices Agency (PMDA), Tokyo, Japan

Plenary 2: Building the Future: Advancing Real-World Evidence in Asia Pacific and Beyond Tuesday 30, September This plenary panel explores the future for RWE in HEOR and addresses questions around HEOR and how to optimize the use of RWE.

Speakers Include:

  • Moderator: Paul Scuffham, PhD, Griffith University, Gold Coast, Australia
  • Bruce Crawford, MA, MPH, Vista Health Japan KK, Tokyo, Japan
  •  Jing Wu, PhD, Tianjin University, Tianjin, China
  • Ji-Hye Byun, PhD, Health Insurance Review & Assessment Service, Wonju , Korea
  • Azuana Ramli, PhD, Ministry of Health, Petaling Jaya, Malaysia

ISPOR is recognized globally as the leading professional society for health economics and outcomes research and for its role in improving healthcare decisions. The Summit draws healthcare stakeholders from the region with an interest in HEOR, including researchers and academicians, assessors and regulators, payers and policymakers, the life sciences industry, healthcare providers, and patient engagement organizations.

Additional information on the conference can be found at:
Conference Information | Program | Press | Exhibits & Sponsorship | Registration

###

ABOUT ISPOR
ISPOR—The Professional Society for Health Economics and Outcomes Research
(HEOR), is an international, multistakeholder, nonprofit dedicated to advancing HEOR excellence to improve decision making for health globally. Society is the leading source for scientific conferences, peer-reviewed and MEDLINE®-indexed publications, good practices guidance, education, collaboration, and tools/resources in the field.
Website
 | LinkedIn  | Twitter (@ispororg)  |  YouTube  |  Facebook  |  Instagram  

 

 

 

 

Related Stories

New ISPOR Report Introduces "IMPACT" Framework to Guide Value-Based Healthcare Implementation

Jul 13, 2026

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced today the publication of an ISPOR Special Task Force Report offering good practice recommendations and a new "IMPACT" framework for integrating health economics and outcomes research (HEOR) methods into value-based healthcare implementation.

Promoting Fairness in Funding Decisions

Jun 24, 2026

Value in Health announced the publication of a special themed section of research papers that offer new tools to help health policy makers weigh fairness alongside cost-effectiveness when deciding which treatments and programs to fund.

Listening to Patients in the Real World

Jun 23, 2026

Value in Health, the official journal of ISPOR announced today the publication of an ISPOR Good Practices Report outlining 9 areas to strengthen the robustness, transparency, and feasibility of real-world patient-reported outcomes studies.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×